Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 1, 1999, Pages 101-107

  Itzhak, Yossef ^a   Martin, Julio L ^a   Black, M Dean ^a   Ali, Syed F ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b National Centre   (United States)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); Cocaine; Dopamine transporter; Locomotoractivity; Nucleus accumbens; Sensitization; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; COCAINE; DOPAMINE TRANSPORTER; NEUROTOXIN;

ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEUROTOXINS; NUCLEUS ACCUMBENS; PSYCHOMOTOR PERFORMANCE;

EID: 0033007060     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00246-9     Document Type: Article

References (42)

1. 3H]GBR-12935 binding after chronic treatment with dopamine active drugs. Psychopharmacology (Berlin). 102:1990;291-294.
2. Benmansour S., Tejani-Butt S.M., Hauptmann M., Brunswick D.J. Lack of effect of high dose cocaine on monoamine uptake sites in rat brain as measured by quantitative autoradiography. Psychopharmacology (Berlin). 106:1992;459-462.
3. Caine S.B., Koob G.F. Effect of mesolimbic dopamine depletion on responding maintained by cocaine and food. J. Exp. Anal. Behav. 61:1994;213-221.
4. Camps M., Ambrosio S., Ballarin M., Reiriz J., Blesa R., Mahy N. Dopamine D1 and D2 receptors visualized in MPTP treated C57BL/6 mice by in vitro autoradiography. Lack of evidence of receptor modifications in Parkinsonian mice Pharmacol. Toxicol. 65:1989;169-174.
5. Cass W.A. Decrease in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J. Pharmacol. Exp. Ther. 280:1997;105-113.
6. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., Perry B.D. Effect of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkeys. Brain Res. 578:1992;235-243.
7. Fornai F., Vaglini F., Maggio R., Bonuccelli U., Corsini G.U. Species differences in the role of excitatory amino acids in experimental parkinsonism. Neurosci. Biobehav. Rev. 21:1997;401-415.
8. Frohna P.A., Rothblat D.S., Joyce J.N., Schneider J.S. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Synapse. 19:1995;46-55.
9. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
10. Gerrits M.A., Van Ree J.M. Effect of nucleus accumbens dopamine depletion on motivation aspects involved in initiation of cocaine and heroin self-administration in rats. Brain Res. 713:1996;114-124.
11. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
12. Gold L.H., Swerdlow N.R., Koob G.F. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behav. Neurosci. 102:1988;544-552.
13. Graham W.C., Clarke C.E., Boyce S., Sambrook M.A., Crossman A.R., Woodruff G.N. Autoradiography studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in monkey (Macaca fascicularis). Brain Res. 514:1990;103-110.
14. Heikkila R.E., Hess A., Duvosin R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
15. Itzhak Y. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J. Pharmacol. Exp. Ther. 282:1997;521-527.
16. Itzhak Y., Gandia C., Huang P.L., Ali S.F. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284:1998;1040-1047.
17. Itzhak Y., Martin J.L., Ali S.F., Norenberg M.D. Depletion of striatal dopamine transporter does not affect psychostimulant-induced locomotor activity. Neuroreport. 8:1997;3245-3249.
18. Izenwasser S., Werling L.L., Cox B.M. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520:1990;303-309.
19. Joyce E., Koob G.F. Amphetamine-, scopolamine-, and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of mesolimbic dopamine system. Psychopharmacology (Berlin). 73:1981;311-313.
20. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
21. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons. Abolition of psychostimulants-induced locomotor activity in rats Eur. J. Pharmacol. 40:1976;45-56.
22. Koob G.F. Neuronal mechanisms of drug reinforcement. Ann. NY Acad. Sci. 654:1992;171-191.
23. Kuhar M.J., Ritz M.C., ;Boja J.W. The dopamine hypothesis in the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
24. Langston J.W., Ballard P., Tetrude J.W., Irwin I. Chronic parkinsonism in humans due to product of meperidine-analog synthesis. Science. 219:1983;979-980.
25. 125I]β-CIT SPECT. Am. J. Psychiatry. 155:1998;832-834.
26. Morissette M., Goulet M., Calon F., Falardeau P., Blanchet P.J., Bedard P., Di Paolo T. Changes in D1 and D2 dopamine receptor mRNA in the brain of monkeys lesioned with MPTP. Correction with chronic administration of L-3,4-dihydroxyphenylalanine J. Pharmacol. Exp. Ther. 50:1996;1073-1079.
27. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
28. Pilotte N.S., Sharp L.G., Kuhar M.J. Withdrawal from repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269:1994;963-969.
29. Post R.M., Weiss S.R., Pert A. Cocaine-induced behavioral sensitization and kindling. Implications for the emergence of psychopathology and seizures Kalivas P.W., Nemeroff C.B. The mesocorticolimbic dopamine system (Annals of the New York Academy of Science, vol. 537). 1988;292-308 The New York Academy of Science, New York.
30. Przedborski S., Jackson-Lewis V., Popilskis S., Kostic V., Levivier M., Fahn S., Cadet J.L. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites. Neurochirurgie. 37:1991;377-382.
31. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
32. Reith M.E.A., Selmeci G. Cocaine binding sites in mouse striatum, dopamine autoreceptors and cocaine-induced locomotion. Pharmacol. Biochem. Behav. 41:1992;227-230.
33. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
34. Roberst D.C., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Bioche. Behav. 12:1980;781-787.
35. Robinson T.E., Berridge K.C. The neural basis of drug craving. An incentive-sensitization theory of addiction Brain Res. Rev. 18:1993;247-291.
36. Robinson T.E., Yew J., Paulson P.E., Camp D.M. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci. Lett. 110:1990;193-198.
37. Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., Mash D.C. High affinity cocaine recognition sites on dopamine transporter are elevated in fetal cocaine overdose victims. J. Pharmacol. Exp. Ther. 271:1994;1678-1685.
38. Schulz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
39. Snyder S.H. Nitric Oxide. First in a new class of neurotransmitter? Science. 257:1992;494-496.
40. Swerdlow N.R., Koob G.F. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine. Pharmacol. Biochem. Behav. 33:1989;595-599.
41. 3H]-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14:1994;2966-2979.
42. Wise B.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.